Development of an anti-microbial peptide-mediated liposomal delivery system: a novel approach towards pH-responsive anti-microbial peptides

Drug Delivery

Volumn 23, Issue 4, 2016, Pages 1163-1170

  Zhang, Qianyu ^a   Tang, Jie ^a   Ran, Rui ^a   Liu, Yayuan ^a   Zhang, Zhirong ^a   Gao, Huile ^a   He, Qin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

AMPs; liposome; tumor delivery; D H6L9 peptide

Indexed keywords

HISTIDINE; LIPOSOME; MACROGOL 2000; POLYPEPTIDE ANTIBIOTIC AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; MACROGOL DERIVATIVE; OLIGOPEPTIDE; PACLITAXEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON TUMOR; DRUG DISTRIBUTION; FLOW CYTOMETRY; IN VIVO STUDY; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTON TRANSPORT; SURFACE CHARGE; TUMOR SPHEROID; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; METABOLISM; PARTICLE SIZE; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MICE; MICE, INBRED BALB C; OLIGOPEPTIDES; PACLITAXEL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION;

EID: 84940784503     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.1003665     Document Type: Article

References (43)

1. A.Almaaytah, M.Zhou, L.Wang,. (2012). Antimicrobial/cytolytic peptides from the venom of the north african scorpion, androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog. Peptides 35:291–9
2. S.Attoub, M.Mechkarska, A.Sonnevend,. (2013). Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells. Peptides 39:95–102
3. A.Bandekar, C.Zhu, A.Gomez,. (2013). Masking and triggered unmasking of targeting ligands on liposomal chemotherapy selectively suppress tumor growth in vivo. Mol Pharm 10:152–60
4. K.L.Brown, R.E.Hancock. (2006). Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 18:24–30
5. L.Chen, Z.Tu, N.Voloshchuk,. (2012). Lytic peptides with improved stability and selectivity designed for cancer treatment. J Pharm Sci 101:1508–17
6. A.Di Francesco, A.Favaroni, M.Donati. (2013). Host defense peptides: general overview and an update on their activity against chlamydia spp. Expert Rev Anti-Infect Therapy 11:1215–24
7. E.C.Dreaden, M.A.El-Sayed. (2012). Emerging nanomaterials for targeting subcellular organelles. Acc Chem Res 45:1854–65
8. C.D.Fjell, J.A.Hiss, R.E.Hancock, G.Schneider. (2011). Designing antimicrobial peptides: form follows function. Nature Rev Drug Discov 11:37–51
9. E.Guaní-Guerra, T.Santos-Mendoza, S.O.Lugo-Reyes,. (2010). Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol 135:1–11
10. R.E.Hancock, H.G.Sahl. (2006). Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnol 24:1551–7
11. G.Helmlinger, F.Yuan, M.Dellian,. (1997). Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nature Med 3:177–82
12. S.T.Henriques, M.N.Melo, M.A.Castanho. (2006). Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem J 399:1–7
13. K.K.Hou, H.Pan, G.M.Lanza, S.A.Wickline. (2013). Melittin derived peptides for nanoparticle based siRNA transfection. Biomaterials 34:3110–19
14. C.Huang, H.Jin, Y.Qian,. (2013). Hybrid melittin cytolytic peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo. ACS Nano 7:5791–5800
15. T.Jiang, Z.Zhang, Y.Zhang,. (2012). Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Biomaterials 33:9246–58
16. M.Kazemzadeh-Narbat, J.Kindrachuk, K.Duan,. (2010). Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections. Biomaterials 31:9519–26
17. M.Kazemzadeh-Narbat, B.F.Lai, C.Ding,. (2013). Multilayered coating on titanium for controlled release of antimicrobial peptides for the prevention of implant-associated infections. Biomaterials 34:5969–77
18. M.L.Mangoni. (2011). Host-defense peptides: from biology to therapeutic strategies. Cell Mol Life Sci 68:2157–9
19. A.A.Manzoor, L.H.Lindner, C.D.Landon,. (2012). Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res 72:5566–75
20. A.Makovitzki, A.Fink, Y.Shai. (2009). Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides. Cancer Res 69:3458–63
21. L.T.Nguyen, E.F.Haney, H.J.Vogel. (2011). The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol 29:464–72
22. N.Papo, D.Seger, A.Makovitzki,. (2006). Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide. Cancer Res 66:5371–8
23. N.Papo, Y.Shai. (2005). Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci 62:784–90
24. J.L.Perry, K.G.Reuter, M.P.Kai,. (2012). PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett 12:5304–10
25. K.V.Reddy, R.D.Yedery, C.Aranha. (2004). Antimicrobial peptides: premises and promises. Int J Antimicrobial Agents 24:536–47
26. S.Riedl, D.Zweytick, K.Lohner. (2011). Membrane-active host defense peptides – challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids 164:766–81
27. F.Salomone, F.Cardarelli, M.Di Luca,. (2012). A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape. J Control Release 163:293–303
28. K.P.Santo, S.J.Irudayam, M.L.Berkowitz. (2013). Melittin creates transient pores in a lipid bilayer: results from computer simulations. J Phys Chem B 117:5031–42
29. K.Splith, I.Neundorf. (2011). Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur Biophys J 40:387–97
30. Y.X.Tan, C.Chen, Y.L.Wang,. (2012). Truncated peptides from melittin and its analog with high lytic activity at endosomal pH enhance branched polyethylenimine-mediated gene transfection. J Gene Med 14:241–50
31. I.F.Tannock, D.Rotin. (1989). Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 49:4373–84
32. L.Tian, Y.H.Bae. (2012). Cancer nanomedicines targeting tumor extracellular pH. Colloids Surf B Biointerfaces 99:116–26
33. Z.Tu, M.Volk, K.Shah,. (2009). Constructing bioactive peptides with pH-dependent activities. Peptides 30:1523–8
34. P.Urbán, J.J.Valle-Delgado, E.Moles,. (2012). Nanotools for the delivery of antimicrobial peptides. Cur Drug Targets 13:1158–72
35. S.Veldhoen, S.D.Laufer, A.Trampe,. (2006). Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect. Nucleic Acids Res 4:6561–73
36. S.Xiang, H.Tong, Q.Shi,. (2012). Uptake mechanisms of non-viral gene delivery. J Control Release 158:371–8
37. S.Xu, B.Z.Olenyuk, C.T.Okamoto,. (2013). Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv Drug Deliv Rev 65:121–38
38. K.Yang, J.Wan, S.Zhang,. (2011). In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano 5:516–22
39. A.T.Yeung, S.L.Gellatly, R.E.Hancock. (2011). Multifunctional cationic host defense peptides and their clinical applications. Cell Mol Life Sci 68:2161–76
40. M.Zasloff. (2002). Antimicrobial peptides of multicellular organisms. Nature 415:389–95
41. W.Zhang, J.Song, B.Zhang,. (2011). Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells. Bioconjugate Chem 22:1410–15
42. Y.Zhang, A.Satterlee, L.Huang. (2012). In vivo gene delivery by nonviral vectors: overcoming hurdles &quest. Mol Therapy 20:1298–304
43. B.X.Zhao, Y.Zhao, Y.Huang,. (2012). The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel. Biomaterials 33:2508–20